Duoplavin for Secondary prevention of atherothrombotic events
Quick answer: Duoplavin is used for Secondary prevention of atherothrombotic events as part of a antiplatelet combination (acetylsalicylic acid + clopidogrel) treatment regimen. Fixed-dose combination of aspirin (COX-1 inhibitor) and clopidogrel (P2Y12 receptor antagonist) inhibiting platelet aggregation via two pathways The specific dosing for Secondary prevention of atherothrombotic events is determined by your prescriber based on individual factors.
Why is Duoplavin used for Secondary prevention of atherothrombotic events?
Duoplavin belongs to the Antiplatelet combination (acetylsalicylic acid + clopidogrel) class. Fixed-dose combination of aspirin (COX-1 inhibitor) and clopidogrel (P2Y12 receptor antagonist) inhibiting platelet aggregation via two pathways This action makes it useful for treating or managing Secondary prevention of atherothrombotic events in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Duoplavin is the right choice for a specific patient depends on the type and severity of Secondary prevention of atherothrombotic events, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Secondary prevention of atherothrombotic events
Common adult dosing range: 75 mg/75 mg or 75 mg/100 mg once daily. The actual dose for Secondary prevention of atherothrombotic events depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Duoplavin medicine page.
What to expect
Duoplavin treatment for Secondary prevention of atherothrombotic events typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Secondary prevention of atherothrombotic events
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Duoplavin is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Antiplatelet combination (acetylsalicylic acid + clopidogrel) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Duoplavin
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Duoplavin full prescribing information · All Antiplatelet combination (acetylsalicylic acid + clopidogrel) alternatives
Frequently asked questions
How effective is Duoplavin for Secondary prevention of atherothrombotic events?
Effectiveness varies by individual response, dose, and severity. Duoplavin is one of several treatment options for Secondary prevention of atherothrombotic events, supported by clinical evidence within the antiplatelet combination (acetylsalicylic acid + clopidogrel) class. Discuss expected response with your prescriber.
How long do I need to take Duoplavin for Secondary prevention of atherothrombotic events?
Treatment duration depends on the nature of Secondary prevention of atherothrombotic events — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Duoplavin when used for Secondary prevention of atherothrombotic events?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Duoplavin for Secondary prevention of atherothrombotic events?
Yes. Multiple medicines and non-drug options exist for Secondary prevention of atherothrombotic events. Alternatives within the antiplatelet combination (acetylsalicylic acid + clopidogrel) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.